googlemarker
Open An Account
Secure With Us
Trade on Mobile

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 361858.24 Face Value (Rs.) : 2 House : Lupin
BSE800.305.05 (+0.64 %)
PREV CLOSE (Rs.) 795.25
OPEN PRICE (Rs.) 800.00
BID PRICE (QTY) 800.30 (90)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 146019
TODAY'S LOW / HIGH (Rs.)792.60 802.60
52 WK LOW / HIGH (Rs.)723.55 1174.85
NSE800.656.1 (+0.77 %)
PREV CLOSE( Rs. ) 794.55
OPEN PRICE (Rs.) 798.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 800.65 (1716)
VOLUME 3233608
TODAY'S LOW / HIGH(Rs.) 792.50 802.40
52 WK LOW / HIGH (Rs.)723.65 1175.2
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1166.52
Dividend Yield(%)
0.62
TTM EPS (Rs.)
29.74
P/E Ratio
26.91
Book Value (Rs.)
344.43
Face Value (Rs.)
2
MCap (Rs. in Mn)
361858.24
Price/Earning (TTM)
20.86
Price/Sales (TTM)
3.59
Price/Book (MRQ)
2.32
PAT Margin (%)
13.33
ROCE (%)
11.72
Incorporation Year : 01-03 1983

Management Info :

Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 6640 2323

Website : www.lupinworld.com

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
20Jul Lupin gains on receiving tentative app
Lupin is currently trading at Rs. 801.00, up by 5.75 points or 0.72% fro..
19Jul Lupin receives tentative approval from
Lupin has received tentative approval for its Tadalafil Tablets USP, 2.5..
19Jul Announcement under Regulation 30 (LOD
Lupin receives tentative FDA approval for generic Tadalafil Tablets USP,..
QTR Mar 18 ANNUAL 18
Net Profit2924.613446.6
Gross Profit 3978.7 17939.3
Operating Profit 5076.8 22169.8
Net Sales 24776 100881.8
Rs. in Millions
Ajanta Pharma (BSE)
img  1017.95 (4.87%)
M.Cap (Rs. in Cr)8959.54
Abbott India (BSE)
img  7305.80 (0.42%)
M.Cap (Rs. in Cr)15524.32
Dr. Reddys Lab (BSE)
img  2055.60 (1.22%)
M.Cap (Rs. in Cr)34122.72
Zim Laboratories (BSE)
img  385.00 (4.90%)
M.Cap (Rs. in Cr)310.30
PROMOTERS
47.01%
NON-INSTITUTION
15.1%
MUTUAL FUNDS/UTI
6.21%
FI/BANKS/INSURANCE
5.48%
GOVERNMENT
0.25%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     912949